[BSTC] BioSpecifics Technologies Corp

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 54.66 Change: 2.27 (4.33%)
Ext. hours: Change: 0 (0%)

chart BSTC

Refresh chart

Strongest Trends Summary For BSTC

BSTC is in the medium-term up 15% in 7 months and down -25% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren?s contracture and Peyronie?s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.

Fundamental Ratios
Shares Outstanding EPS1.63 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 111.07% Sales Growth - Q/Q20.56% P/E29.54
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.95% ROE18.48% ROI
Current Ratio31.82 Quick Ratio Long Term Debt/Equity Debt Ratio0.03
Gross Margin Operating Margin55.74% Net Profit Margin36.77% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.08 M Cash From Investing Activities-2.15 M Cash From Operating Activities1.99 M Gross Profit
Net Profit2.33 M Operating Profit3.56 M Total Assets34.67 M Total Current Assets28.99 M
Total Current Liabilities910 K Total Debt Total Liabilities1000 K Total Revenue5.61 M
Technical Data
High 52 week71.62 Low 52 week49.72 Last close49.91 Last change0.14%
RSI15.08 Average true range1.91 Beta0.4 Volume22.66 K
Simple moving average 20 days-7.28% Simple moving average 50 days-10.22% Simple moving average 200 days-19.18%
Performance Data
Performance Week-2.29% Performance Month-14.44% Performance Quart-20.02% Performance Half-24.95%
Performance Year-15.05% Performance Year-to-date-17.64% Volatility daily1.2% Volatility weekly2.69%
Volatility monthly5.52% Volatility yearly19.12% Relative Volume155.17% Average Volume48.38 K
New High3.64% New Low

News

2020-05-16 08:30:06 | One Analyst Thinks BioSpecifics Technologies Corp.'s NASDAQ:BSTC Revenues Are Under Threat

2020-05-11 08:05:00 | BioSpecifics Reports First Quarter 2020 Financial and Operating Results

2020-05-11 08:00:00 | BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer

2020-05-07 09:49:01 | Zacks.com featured highlights include: BioSpecificsTechnologies, eXp World, Elbit Systems and KoninklijkeVopak

2020-04-29 11:30:03 | Is BioSpecifics Technologies BSTC Stock Outpacing Its Medical Peers This Year?

2020-04-29 06:58:02 | Are Robust Financials Driving The Recent Rally In BioSpecifics Technologies Corp.'s NASDAQ:BSTC Stock?

2020-04-23 11:33:03 | New Strong Buy Stocks for April 23rd

2020-04-21 12:22:04 | Zacks.com featured highlights include: PJT Partners, CBIZ, BioSpecifics Technologies, eXp World and Gibraltar Industries

2020-04-20 09:17:01 | 5 Stocks With Rising Cash Flows to Battle Coronavirus Crisis

2020-04-17 09:40:01 | Zacks.com featured highlights include: Gibraltar Industries, CBIZ, Integer, BioSpecifics Technologies and DHT

2020-04-16 07:27:11 | Check These 7 Top-Ranked Stocks With Solid Net Profit Margins

2020-04-15 10:19:02 | New Strong Buy Stocks for April 15th

2020-04-10 16:00:00 | BioSpecifics Adopts Replacement Stockholder Rights Plan

2020-04-10 11:30:03 | Is BioSpecifics Technologies BSTC Outperforming Other Medical Stocks This Year?

2020-04-09 08:05:00 | BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors

2020-04-09 08:00:00 | BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer

2020-04-07 12:00:04 | BioSpecifics BSTC Upgraded to Strong Buy: Here's Why

2020-04-02 10:22:02 | Yes, You Can Time the Market. Find out How - April 02, 2020

2020-03-30 13:52:05 | These Stocks Are Potentially Undervalued

2020-03-19 06:21:35 | How Does BioSpecifics Technologies's NASDAQ:BSTC P/E Compare To Its Industry, After The Share Price Drop?

2020-03-16 16:01:00 | BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

2020-03-03 09:00:28 | These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why

2020-02-20 06:34:25 | Does The BioSpecifics Technologies Corp. NASDAQ:BSTC Share Price Fall With The Market?

2020-02-14 05:00:00 | Small Cap Play on Collagenase-Based Therapies

2020-02-05 09:23:02 | When Does Market Timing Actually Work? - February 05, 2020

2020-01-21 05:56:58 | Do BioSpecifics Technologies's NASDAQ:BSTC Earnings Warrant Your Attention?

2020-01-17 09:34:02 | How to Time the Markets Like an Investing Pro - January 17, 2020

2019-12-24 09:37:02 | The Market Timing Secrets No One Talks About - December 24, 2019

2019-12-22 08:15:37 | Calculating The Fair Value Of BioSpecifics Technologies Corp. NASDAQ:BSTC

2019-12-13 12:38:10 | Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. BSTC

2019-12-04 08:36:01 | Simple Market Timing Strategies That Work - December 04, 2019

2019-11-22 07:11:21 | Here's How P/E Ratios Can Help Us Understand BioSpecifics Technologies Corp. NASDAQ:BSTC

2019-11-14 08:53:01 | The Truth About Market Timing - November 14, 2019

2019-11-08 09:25:02 | BioSpecifics Technologies BSTC Q3 Earnings and Revenues Beat Estimates

2019-11-08 08:01:00 | BioSpecifics Reports Third Quarter 2019 Financial and Operating Results

2019-11-01 10:30:02 | BioSpecifics Technologies BSTC to Report Q3 Results: Wall Street Expects Earnings Growth

2019-10-31 14:20:34 | Here’s What Hedge Funds Think About BioSpecifics Technologies Corp. BSTC

2019-10-24 09:00:01 | The Truth About Market Timing - October 24, 2019

2019-10-23 08:01:00 | Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

2019-10-21 07:17:13 | Is BioSpecifics Technologies Corp.'s NASDAQ:BSTC 20% ROE Better Than Average?

2019-10-17 09:00:01 | BioSpecifics BSTC Upgraded to Buy: Here's Why

2019-10-10 08:01:00 | BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer

2019-10-03 08:49:12 | When Does Market Timing Actually Work? - October 03, 2019

2019-09-25 14:38:57 | Have Insiders Been Selling BioSpecifics Technologies Corp. NASDAQ:BSTC Shares?

2019-09-13 08:39:12 | The Truth About Market Timing - September 13, 2019

2019-09-10 04:56:08 | Endo Files BLA for CCH With the FDA for Cellulite Candidate Revised

2019-09-09 09:50:01 | Endo International Files BLA for Label Expansion of Xiaflex

2019-09-03 06:14:26 | What Kind Of Share Price Volatility Should You Expect For BioSpecifics Technologies Corp. NASDAQ:BSTC?

2019-08-26 08:37:12 | Yes, You Can Time the Market. Find out How - August 26, 2019

2019-08-11 09:51:16 | If You Had Bought BioSpecifics Technologies NASDAQ:BSTC Stock Five Years Ago, You Could Pocket A 91% Gain Today